MONTREAL, May 28, 2012 /CNW Telbec/ - We are pleased to announce the appointment of Mr. Martyn Coombs as President, Jubilant DraxImage Inc. at Montreal, Canada with effect from May 23, 2012.
Prior to joining Jubilant DraxImage, Mr. Coombs served as CEO of Asterand PLC from 2007 to 2011.
During his term, he received an award from the Financial Times for the top performing stock on the London Stock Exchange, out of over 2,000 companies.
Previously, he served in Japan for five years as Executive Vice President of Nihon Medi-Physics Co. Ltd.
He has also held several executive positions with large international organizations such as Amersham PLC and PerkinElmer Inc.
Mr. Coombs holds a degree in Mathematics and an MBA with distinction from Warwick Business School.
About Jubilant DraxImage Inc.
Jubilant DraxImage Inc., a subsidiary of Jubilant Life Sciences, develops, manufactures and markets diagnostic and therapeutic radiopharmaceuticals for the global nuclear medicine marketplace.
Products includes a proprietary line of lyophilized Technetium-99m kits (MAA, MDP, DTPA and Sestamibi).
Jubilant DraxImage Inc. is also a leading supplier of I-131 radiopharmaceuticals in North America, used for the diagnosis and treatment of thyroid disorder and cancer.
Products in development comprises "next generation" Rubidium-82 and Technetium-99m generators.
Jubilant DraxImage Inc. products are exported worldwide, with regulatory approval in USA, South America, parts of Europe and South-East Asia.
Image with caption: "Martyn Coombs, President of Jubilant DraxImage Inc. (CNW Group/Jubilant DraxImage Inc.)". Image available at: http://photos.newswire.ca/images/download/20120528_C3061_PHOTO_EN_14223.jpg
For further information:
Senior Manager - Corporate Communicaton
Jubilant Life Sciences Ltd.
1A, Sector-16A, HO Noida - 201301
T: 01204361034, M: 919811219334
E-mail : email@example.com